3.25 USD
↘ 0.05 (1.52%)AT CLOSE (11:59 AM EDT)
Lisata Therapeutics, Inc. Common Stock
LSTANASDAQ • USD
4.19
↗ 0.94 (28.92%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
4.19
↗ 0.94 (28.92%)
Market: CLOSED
Open?$3.25
High?$3.36
Low?$3.10
Prev. Close?$3.30
Volume?1.8M
Avg. Volume?106.3K
VWAP?$3.25
Rel. Volume?16.58x
Bid / Ask
Bid?$4.17 × 1.0K
Ask?$4.19 × 200
Spread?$0.02
Midpoint?$4.18
Valuation & Ratios
Market Cap?29.6M
Shares Out?9.1M
Float?6.6M
Float %?75.1%
P/E Ratio?N/A
P/B Ratio?2.71
EPS?-$1.80
Dividend?0.00%
Ex-Dividend?N/A
Lisata Therapeutics, Inc. Common Stock (LSTA) is currently trading at $3.25. The technical outlook is "Neutral" and the fundamental picture shows "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. LSTA is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of May 29, 2026.
News
Profile
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
Themes
Address
110 ALLEN ROAD
BASKING RIDGE, NJ 07920
Phone: 908-229-2590
BASKING RIDGE, NJ 07920
Phone: 908-229-2590
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?54
Piotroski F-Score?0/9Weak
Altman Z-Score?-54.57Distress
Confidence?41%Low
Short InterestLow
Short % of Float?1.41%Low
Short Interest?93.5K
Days to Cover?3.0
Free Float6.6M
Avg Daily Volume31.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?4.23Strong
Quick Ratio?4.23Strong
Cash Ratio?3.94Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.71CHEAP▾
Peers100
S&P60
P/S?174.09HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-1.0CHEAP▾
S&P97
EV/Sales?97.27HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-149.7%WEAK▾
S&P3
ROA?-116.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-13630000
Enterprise Value?$16.5M
Fundamentals ratios updated end of day